MENU
BOUT
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

BOUT stock forecast, quote, news & analysis

The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index")... Show more

Category: #Mid-Cap Growth
BOUT
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for BOUT with price predictions
Jul 31, 2026

BOUT's Stochastic Oscillator dives into oversold zone

The Stochastic Oscillator for BOUT moved into oversold territory on July 31, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BOUT advanced for three days, in of 352 cases, the price rose further within the following month. The odds of a continued upward trend are .

BOUT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BOUT as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BOUT turned negative on July 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

BOUT moved below its 50-day moving average on July 10, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BOUT crossed bearishly below the 50-day moving average on July 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BOUT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BOUT entered a downward trend on July 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Alibaba Group Holding Limited (NYSE:BABA), Amgen (NASDAQ:AMGN), Charles Schwab Corp (The) (NYSE:SCHW), Enterprise Products Partners LP (NYSE:EPD), Kinder Morgan (NYSE:KMI), Targa Resources Corp (NYSE:TRGP), Wheaton Precious Metals Corp (NYSE:WPM), Hess Corp (null:HES), EQT Corp (NYSE:EQT), Okta (NASDAQ:OKTA).

Industry description

The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund normally invests at least 80% of its net assets (including borrowings for investment purposes) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock’s recent “resistance level,” with consideration for various market conditions. The fund is non-diversified.

Market Cap

The average market capitalization across the CapForce IBD® Breakout Opportunities ETF ETF is 130.15B. The market cap for tickers in the group ranges from 605.18M to 286.04B. BABA holds the highest valuation in this group at 286.04B. The lowest valued company is NPB at 605.18M.

High and low price notable news

The average weekly price growth across all stocks in the CapForce IBD® Breakout Opportunities ETF ETF was -0%. For the same ETF, the average monthly price growth was -4%, and the average quarterly price growth was 20%. SFM experienced the highest price growth at 16%, while CVLT experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the CapForce IBD® Breakout Opportunities ETF ETF was 18%. For the same stocks of the ETF, the average monthly volume growth was -7% and the average quarterly volume growth was -34%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 63
Price Growth Rating: 48
SMR Rating: 52
Profit Risk Rating: 50
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
BOUT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category MidCapGrowth

Profile
Details
Category
Mid-Cap Growth
Address
Academy Funds Trust123 South Broad Street, Suite 1630Philadelphia
Phone
(215) 979-3750
Web
www.innovatorfunds.com
BOUT's Stochastic Oscillator dives into oversold zone